Onderneming OUTLOOK THERAPEUTICS, INC. Nasdaq
Aandelen
US68235M1053
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01-11-18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02-03-22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08-02-22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01-11-18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13-04-18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11-12-15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31-10-17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20-04-20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20-04-20 |
Julia Haller
BRD | Director/Board Member | 69 | 11-08-22 |
Director/Board Member | 39 | 11-09-17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 22 298 542 | 13 636 212 ( 61,15 %) | 0 | 61,15 % |
Bedrijfsgegevens
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,67% | 42,4 mld. | |
+44,30% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,94 mld. | |
-21,66% | 18,96 mld. | |
+29,96% | 12,3 mld. | |
-1,57% | 11,95 mld. | |
+16,03% | 11,32 mld. | |
-4,80% | 11,55 mld. |